- 0.6Impact Factor
- 22 daysTime to First Decision
Reports, Volume 7, Issue 4
December 2024 - 38 articles
Cover Story: The current case report examines the correlation between intravenous infusion parameters and possible ocular adverse effects potentially related to voriconazole therapy. A 32-year-old female patient had hallucinations and visual disturbances following the initial administration of voriconazole for recurrent severe vulvovaginitis attributed to Candida glabrata. The symptoms abated following a reduction in dosage and infusion rate, in accordance with the clinical pharmacist's advice. This example underscores the adverse drug reactions associated with voriconazole, especially those resulting from improper infusion rates, and emphasizes the critical role of clinical pharmacists in managing these responses. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Reports - ISSN 2571-841X